background image

Melanoma Clinical Trials

Find clinical trials for melanoma. Search for melanoma clinical trials in different cities and states across the United States.

Filter
1
Active & ResponsiveNew

The Florida ASCENT Study

for
Cancer, Food Deprivation, Food Habits, Food Selection,
Location: 1 recruiting location
Sponsor: University of Florida

Sex: All

Age: 18 - 70+

Code: NCT07042243

Recruiting
Active & Responsive

Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi

for
Melanoma
Location: 1 recruiting location
Sponsor: John Kirkwood

Sex: All

Age: 18+

Code: NCT06599619

Recruiting
Active & Responsive

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

for
Uveal Neoplasms, Melanoma, Uveal
Location: 1 recruiting location
Sponsor: Udai Kammula

Sex: All

Age: 18 - 70+

Code: NCT03467516

Phase2, Recruiting
Active & Responsive

DermaSensor Postmarket Surveillance Study

for
Melanoma, Skin
Location: 2 recruiting locations
Sponsor: DermaSensor, Inc.

Sex: All

Age: 40+

Code: NCT06666790

Recruiting
Active & Responsive

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

for
Pleural Effusion, Malignant, Ascites, Malignant, Carcinoma,
Location: 1 recruiting location
Sponsor: Travera Inc

Sex: All

Age: 18+

Code: NCT05461430

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

In Vivo Liquid Biopsy of Melanoma (Cytophone)

for
Melanoma, Circulating Tumor Cells, Metastatic Melanoma,
Location: 1 recruiting location
Sponsor: Cytoastra

Sex: All

Age: 18 - 70+

Code: NCT06488365

Recruiting
Active & Responsive

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

for
Advanced Melanoma
Location: 17 recruiting locations
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT05549297

Phase3, Recruiting
Active & Responsive

Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma

for
Melanoma, Unresectable Solid Tumors, Neoplasms,
Location: 2 recruiting locations
Sponsor: Yana Najjar

Sex: All

Age: 18+

Code: NCT04572451

Phase1, Recruiting
Active & Responsive

Evaluation of Hypoxia in Primary Melanoma

for
Melanoma
Location: 1 recruiting location
Sponsor: Yana Najjar

Sex: All

Age: 18+

Code: NCT06831071

Recruiting
Active & Responsive

A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

for
Advanced Solid Tumor, Locally Advanced Solid Tumor,
Location: 14 recruiting locations
Sponsor: Ascendis Pharma Oncology Division A/S

Sex: All

Age: 18+

Code: NCT05081609

Phase1, Phase2, Recruiting